Skip to main content
main-content

Lung cancer

31-01-2019 | Lung cancer | News | Article

Lung cancer OS benefit with patient-reported symptom monitoring

A web-based patient-reported system for monitoring symptoms after treatment for lung cancer is associated with significantly better overall survival than standard scheduled imaging, trial results show.

30-01-2019 | Non-small-cell lung cancer | News | Article

MET copy number gain insignificant for TKI response in EGFR-positive NSCLC

The level of mesenchymal epithelial transition factor copy number gain does not affect response to tyrosine kinase inhibitors in patients with metastatic epidermal growth factor receptor-mutated non-small-cell lung cancer, research shows.

18-01-2019 | Non-small-cell lung cancer | News | Article

Prolonged OS possible for ALK-positive stage IV NSCLC

Individuals with stage IV non-small-cell lung cancer harboring anaplastic lymphoma kinase translocations can hope to achieve overall survival of nearly 7 years, suggests a US cohort analysis.

15-01-2019 | Non-small-cell lung cancer | News | Article

miRNA signature could supplement PD-L1 as NSCLC immunotherapy marker

Combining a plasma-based microRNA signature with tumoral tissue expression of programmed cell death ligand 1 could help identify advanced non-small-cell lung cancer patients who are unlikely to benefit from immune checkpoint inhibition, suggests an exploratory study.

11-01-2019 | Oncology | News | Article

Concomitant TKI–PPI use may adversely affect cancer patient survival

Taking proton pump inhibitors alongside tyrosine kinase inhibitors is associated with an increased mortality risk in older cancer patients, research indicates.

10-01-2019 | Non-small-cell lung cancer | News | Article

Autoimmune antibodies predict clinical benefit, adverse events in NSCLC

The presence of some autoimmune antibodies prior to treatment with programmed cell death protein 1 inhibitors is associated with both clinical benefit and immune-related adverse events in patients with non-small-cell lung cancer, researchers report.

image credits